Inventor
HUMPHREYS DAVID PAUL
GB46 patents
⚠️ This page may combine multiple inventors who share the name “HUMPHREYS DAVID PAUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UCB PHARMA SA
19 patentsUS9309327B2Apr 12, 2016
Dual specificity antibody fusions
UCB PHARMA SA32 citations96
US9040048B2May 26, 2015
Antibody molecules having specificity for human OX40
UCB PHARMA SA19 citations92
US9550973B2Jan 24, 2017
Bacterial host strain
UCB PHARMA SA5 citations84
US9315770B2Apr 19, 2016
Bacterial host strain
UCB PHARMA SA11 citations84
US8053562B2Nov 8, 2011
Modified antibody fragments
UCB PHARMA SA13 citations84
US10100130B2Oct 16, 2018
Dual specificity antibody fusions
UCB PHARMA SA5 citations83
US9828438B2Nov 28, 2017
Dual specificity antibody fusions
UCB PHARMA SA7 citations83
US9587227B2Mar 7, 2017
Bacterial host strain comprising a mutant spr gene and having reduced Tsp activity
UCB PHARMA SA2 citations73
US9493559B2Nov 15, 2016
Bacterial host strain expressing recombinant DsbC and having reduced Tsp activity
UCB PHARMA SA5 citations73
US9493558B2Nov 15, 2016
Bacterial host strain comprising a mutant SPR gene and a wild-type TSP gene
UCB PHARMA SA5 citations73
US10421816B2Sep 24, 2019
Multivalent antibodies
UCB PHARMA SA2 citations72
US9902768B2Feb 27, 2018
Sequence asymmetric modified IgG4 bispecific antibodies
UCB PHARMA SA5 citations71
US9951365B2Apr 24, 2018
Recombinant bacterial host cell for protein expression
UCB PHARMA SA4 citations68
US7989594B2Aug 2, 2011
Modified antibody fab fragments
UCB PHARMA SA5 citations63
US11427650B2Aug 30, 2022
Dual specificity antibody fusions
UCB PHARMA SA0 citations61
US12091450B2Sep 17, 2024
Antibodies of the class IGG4
UCB PHARMA SA0 citations59
US10759844B2Sep 1, 2020
Disulfide stabilised antibodies and fragments thereof
UCB PHARMA SA0 citations52
US9957328B2May 1, 2018
Bacterial host strain expressing recombinant DSBC
UCB PHARMA SA1 citations52
US7662609B2Feb 16, 2010
E.coli host cells with modified PhoS/PstS periplasmic phosphate-binding proteins, and method of manufacturing recombinant fabs
UCB PHARMA SA1 citations50
UCB BIOPHARMA SPRL
8 patentsUS9873735B2Jan 23, 2018
Method of treatment with antibodies having specificity for human OX40
UCB BIOPHARMA SPRL12 citations83
US9803004B2Oct 31, 2017
Albumin binding antibodies and binding fragments thereof
UCB BIOPHARMA SPRL10 citations83
US11059911B2Jul 13, 2021
Sequence symmetric modified IgG4 bispecific antibodies
UCB BIOPHARMA SPRL8 citations82
US10221251B2Mar 5, 2019
Sequence symmetric modified IGG4 bispecific antibodies
UCB BIOPHARMA SPRL11 citations82
US10457748B2Oct 29, 2019
Single linker FabFv antibodies and methods of producing same
UCB BIOPHARMA SPRL3 citations72
US10023631B2Jul 17, 2018
Albumin binding antibodies and binding fragments thereof
UCB BIOPHARMA SPRL3 citations72
US11401349B2Aug 2, 2022
Single linker FabFv antibodies and methods of producing same
UCB BIOPHARMA SPRL0 citations62
US11352414B2Jun 7, 2022
Multimeric Fc proteins
UCB BIOPHARMA SPRL0 citations46
ELLIS MARK
5 patentsUS9109216B2Aug 18, 2015
Bacterial host strain
ELLIS MARK14 citations92
US8969037B2Mar 3, 2015
Bacterial host strain comprising a mutant spr gene and a wild-type Tsp gene
ELLIS MARK12 citations84
US8969039B2Mar 3, 2015
Bacterial host strain comprising a mutant SPR gene and having reduced TSP activity
ELLIS MARK14 citations84
US8969038B2Mar 3, 2015
Bacterial host strain expressing recombinant DsbC and having reduced Tsp activity
ELLIS MARK14 citations84
US9725516B2Aug 8, 2017
Bacterial host strain expressing recombinant DSBC
ELLIS MARK3 citations73
HUMPHREYS DAVID PAUL
5 patentsUS8629246B2Jan 14, 2014
Dual specificity antibody fusions
HUMPHREYS DAVID PAUL21 citations90
US10562966B2Feb 18, 2020
Antibodies of the class IGG4
HUMPHREYS DAVID PAUL4 citations69
US9045529B2Jun 2, 2015
Disulfide stabilized antibodies and fragments thereof
HUMPHREYS DAVID PAUL2 citations62
US8062865B2Nov 22, 2011
Expression control using antibody expression optimisation sequences
HUMPHREYS DAVID PAUL1 citations51
US10752676B2Aug 25, 2020
Neutralising antibodies to the major exotoxins TCDA and TCDB of Clostridium difficile
HUMPHREYS DAVID PAUL0 citations32
UCB Biopharma SRL
5 patentsUS12428497B2Sep 30, 2025
Multispecific antibody constructs
UCB Biopharma SRL0 citations61
US11345760B2May 31, 2022
Multispecific antibody constructs
UCB Biopharma SRL1 citations61
US11091542B2Aug 17, 2021
Antibody molecules which bind TNF alpha
UCB Biopharma SRL0 citations61
US11261470B2Mar 1, 2022
Recombinant bacterial host cell for protein expression
UCB Biopharma SRL1 citations57
US12570738B2Mar 10, 2026
Multi-specific antibody with binding specificity for human IL-13 and IL-17
UCB Biopharma SRL0 citations53